Diethylene glycol (DEG) residue safety assessment is a critical quality control and toxicological evaluation process used to detect and quantify DEG contamination in glycerin, propylene glycol, pharmaceutical syrups, cosmetics, and food products. This technical guide covers international regulatory limits (USP, Ph. Eur., ChP, ICH, ISO, GB), validated analytical methods such as GC-FID and GC-MS, sampling requirements, and practical applications for manufacturers, importers, and regulators worldwide.
Technical Overview
Diethylene glycol (DEG, CAS 111-46-6) is a colorless, hygroscopic, water-miscible diol produced as a co-product of ethylene glycol manufacture. Although useful industrially as a solvent and humectant, DEG is a notorious toxic contaminant: because it shares a sweet taste, viscosity, and solvency profile with glycerin and propylene glycol, it has repeatedly entered pharmaceutical, food, and cosmetic supply chains through adulterated or inadequately refined excipients. In the human body, DEG is metabolized to 2-hydroxyethoxyacetaldehyde and diglycolic acid, which cause acute kidney injury (proximal tubular necrosis), central nervous system depression, metabolic acidosis, and hepatotoxicity.
Successive poisoning tragedies involving contaminated oral liquid medicines, from the 1937 sulfanilamide elixir disaster to the cough syrup contamination events publicized in 2022 and 2023, established DEG as one of the most consequential excipient impurities in modern pharmacovigilance. In response, major pharmacopoeias, including USP, the European Pharmacopoeia (Ph. Eur.), and the Chinese Pharmacopoeia (ChP), enforce strict limits of not more than 0.1% (1000 ppm) each for DEG and ethylene glycol (EG) in glycerin and propylene glycol, verified by chromatographic testing.
A complete DEG residue safety assessment integrates four risk-analysis elements: hazard identification (toxicological profile), hazard characterization (tolerable intake values on the order of 0.5 mg/kg body weight per day have been proposed in published risk assessments), exposure assessment (measured residue levels versus the maximum daily dose), and risk characterization (comparison with applicable regulatory limits). Testing is typically performed by accredited third-party laboratories operating under ISO/IEC 17025 quality systems and using analytical methods validated in accordance with ICH Q2(R2).
Testing Samples
Safety assessments can be performed across the entire product lifecycle, from incoming raw material qualification to finished product release and post-market surveillance. Because DEG contamination is rarely homogenous, statistically representative sampling plans and intact container integrity are essential for defensible results. Typical submissions comprise 50 to 100 g or mL of material sealed in airtight glass containers with full chain-of-custody documentation.
Pharmaceutical Excipients
Glycerin (glycerol), propylene glycol, liquid polyethylene glycols (PEG 200 to 600), polysorbates 20, 60, and 80, and sorbitol or maltitol solutions are the highest-risk materials. Current good manufacturing practice expectations combine identity verification of every incoming container by FTIR or Raman spectroscopy with quantitative DEG and EG impurity testing on representative samples from each shipment.
Oral Liquid and Syrup Preparations
Cough and cold syrups, antihistamine liquids, paracetamol and ibuprofen suspensions, and pediatric drops are tested for both process-related residues and excipient-derived contamination, with exposure evaluated against the maximum labeled daily dose for the most vulnerable patient population.
Cosmetics and Personal Care Products
Toothpaste, mouthwash, lotions, creams, deodorants, and other formulations containing humectants or ethoxylated emulsifiers are assessed against trace-level impurity expectations, including Chinese national requirements such as GB/T oral care standards and the Safety and Technical Standards for Cosmetics.
Food, Flavor, and Consumer Products
Food-grade glycerin (E 422), flavor and fragrance carriers, e-liquids, and household chemical products are tested against food additive purity specifications and relevant GB standards to verify compliance before distribution.
Testing Items
A comprehensive DEG residue safety assessment typically includes the following deliverables:
- Quantitative determination of DEG content in percent by weight or ppm, with a method limit of quantification (LOQ) of 10 to 25 ppm or lower to demonstrate compliance margin.
- Co-determination of ethylene glycol (EG) and triethylene glycol (TEG), which frequently accompany DEG as co-contaminants.
- Excipient identity confirmation by FTIR or Raman spectroscopy to detect economically motivated substitution of glycerin with toxic glycols.
- Related substances and impurity profiling of the full low-molecular-weight glycol distribution in the sample matrix.
- Risk-based exposure calculation comparing measured residues, maximum daily dose, and body-weight-adjusted tolerable intake values.
- Method validation package in accordance with ICH Q2(R2), covering specificity, linearity, range, accuracy, precision, LOQ, LOD, and robustness.
- Stability testing and packaging interaction (leachable and extractable) studies where migration or degradation pathways are plausible.
Testing Methods
Gas chromatography is the internationally recognized platform for DEG residue determination, supported by mass spectrometric confirmation for regulatory-grade certainty. Methods are validated, verified in the target matrix, and controlled through documented system suitability criteria before sample analysis.
Sample Preparation
Simple matrices such as neat glycerin or propylene glycol are analyzed by a dilute-and-shoot approach in a suitable solvent. Syrups, toothpastes, and creams may require liquid-liquid extraction or solid-phase extraction cleanup to remove sugars, abrasives, and surfactants. Where peak shape or volatility is problematic, derivatization with silylating reagents such as BSTFA improves chromatographic performance. Internal standards, for example 1,4-butanediol or isotopically labeled analogues, are added prior to preparation to correct for injection variability and recovery losses.
GC-FID Screening and Quantification
Gas chromatography with flame ionization detection is the workhorse technique codified in pharmacopoeial monographs. Separation on a polar capillary column with programmed temperature rise resolves EG, DEG, and TEG from the excipient matrix, with system suitability criteria addressing resolution between adjacent glycol peaks, peak tailing, and replicate injection precision. LOQ values in the low ppm range comfortably support the 0.1% specification limit.
GC-MS Confirmation
Electron-impact GC-MS operated in selected-ion monitoring mode provides unambiguous identification based on retention time and characteristic ion ratios, with sensitivity extending to sub-ppm levels. GC-MS confirmation is recommended for positive findings, complex cosmetic or botanical matrices, and resolution of disputed or out-of-specification results.
Complementary and Orthogonal Techniques
HPLC with refractive index detection and LC-MS/MS using hydrophilic interaction chromatography offer alternatives for thermolabile or highly polar matrices, while two-dimensional chromatography can be deployed for exceptionally complex formulations. All testing is conducted within an ISO/IEC 17025 quality framework including certified reference materials, matrix-spiked recovery controls, measurement uncertainty estimation, and structured out-of-specification investigation procedures with orthogonal confirmation.
Applications
DEG residue safety assessments support quality, regulatory, and commercial decisions across multiple industries:
- GMP release testing of incoming glycerin, propylene glycol, and PEG lots prior to pharmaceutical manufacturing.
- Supplier qualification, supply chain security programs, and verification of certificates of analysis.
- Finished product batch certification and shelf-life stability programs for oral liquid medicines.
- Cosmetic product safety dossiers demonstrating compliance with EU and Chinese trace impurity requirements.
- Food additive specification compliance for glycerin and flavor carriers under GB and international standards.
- Import and export batch verification, market surveillance, and customs clearance support.
- Root-cause investigation of contamination events, recall scope definition, and remediation validation.
- Research applications including packaging migration studies and process residual evaluation.
FAQ
What is the regulatory limit for DEG residue?
USP, Ph. Eur., and ChP monographs harmonize on a limit of not more than 0.1% (1000 ppm) each for DEG and ethylene glycol in glycerin and propylene glycol. For finished products, compliance is judged by a risk-based exposure calculation comparing the residue level against tolerable daily intake values rather than a single universal threshold.
Why does DEG appear in glycerin and other excipients?
DEG enters excipients through three principal routes: economically motivated adulteration of glycerin with cheaper toxic glycols, incomplete purification during co-production with ethylene glycol, and cross-contamination in shared storage or transport equipment. Falsified certificates of analysis remain a documented risk, which is why direct laboratory testing of every shipment is strongly advised.
Which analytical method is most appropriate?
GC-FID following the pharmacopoeial approach is suitable for routine screening and quantification, while GC-MS confirmation provides definitive identification when results approach or exceed limits, when matrices are complex, or when findings will support regulatory action.
What sample size and packaging are required for submission?
Typically 50 to 100 g or mL of homogeneous representative material is sufficient. Samples should be sealed in airtight glass containers because DEG and glycerin are hygroscopic, labeled with batch details, and shipped at ambient temperature with chain-of-custody documentation.
How sensitive are the methods?
Validated GC-FID methods routinely achieve LOQ values of 10 to 50 ppm, while GC-MS in selected-ion monitoring mode can reach sub-ppm detection limits. These sensitivities provide a substantial margin below the 1000 ppm pharmacopoeial limit.
Can DEG residues be removed from a finished product?
No practical reprocessing step reliably removes DEG from a finished oral liquid or cosmetic formulation. Prevention through supplier qualification, 100% container identity testing, and batch-by-batch chromatographic impurity testing is the only reliable control strategy, and non-conforming material should be rejected at the incoming stage.